Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant
- PMID: 1465617
- DOI: 10.1126/science.1465617
Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant
Abstract
Class II major histocompatibility complexes bind peptides in an endosome-like compartment. When the class II null cell line 721.174 was transfected with class II DR3 genes, DR molecules were produced in normal amounts. However, the DR molecules were abnormally conformed and unstable because deletion of an antigen-processing gene had impaired intracellular formation of most class II-peptide complexes. Yet, 70 percent of the DR molecules still bore peptides, 80 percent of which were 21- to 24-amino acid fragments of the class II-associated invariant chain. These peptides were rare on DR3 from control cells. Thus, a defect in the main antigen-processing pathway revealed a process in which DR molecules bind long peptides derived from proteins present in the same compartment.
Similar articles
-
A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides.J Exp Med. 1994 Feb 1;179(2):541-9. doi: 10.1084/jem.179.2.541. J Exp Med. 1994. PMID: 8294865 Free PMC article.
-
Point mutations in or near the antigen-binding groove of HLA-DR3 implicate class II-associated invariant chain peptide affinity as a constraint on MHC class II polymorphism.J Immunol. 2003 May 1;170(9):4683-92. doi: 10.4049/jimmunol.170.9.4683. J Immunol. 2003. PMID: 12707347
-
Masking of a cathepsin G cleavage site in vivo contributes to the proteolytic resistance of major histocompatibility complex class II molecules.Immunology. 2010 Jul;130(3):436-46. doi: 10.1111/j.1365-2567.2010.03247.x. Epub 2010 Mar 17. Immunology. 2010. PMID: 20331476 Free PMC article.
-
HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules.J Exp Med. 1996 Dec 1;184(6):2153-65. doi: 10.1084/jem.184.6.2153. J Exp Med. 1996. PMID: 8976171 Free PMC article.
-
HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides.Nature. 1992 Dec 3;360(6403):474-7. doi: 10.1038/360474a0. Nature. 1992. PMID: 1448172
Cited by
-
Degradation of mouse invariant chain: roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism.J Exp Med. 1997 Aug 18;186(4):549-60. doi: 10.1084/jem.186.4.549. J Exp Med. 1997. PMID: 9254653 Free PMC article.
-
Functionality of major histocompatibility complex class II molecules in mice doubly deficient for invariant chain and H-2M complexes.Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9255-60. doi: 10.1073/pnas.94.17.9255. Proc Natl Acad Sci U S A. 1997. PMID: 9256469 Free PMC article.
-
Novel mutants define genes required for the expression of human histocompatibility leukocyte antigen DM: evidence for loci on human chromosome 6p.J Exp Med. 1997 Nov 3;186(9):1469-80. doi: 10.1084/jem.186.9.1469. J Exp Med. 1997. PMID: 9348304 Free PMC article.
-
Selective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pH.J Exp Med. 1994 Aug 1;180(2):751-5. doi: 10.1084/jem.180.2.751. J Exp Med. 1994. PMID: 8046351 Free PMC article.
-
Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins.Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7217-21. doi: 10.1073/pnas.92.16.7217. Proc Natl Acad Sci U S A. 1995. PMID: 7638170 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
